In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
December 11th, 2008 | 33 | Yes |
Popular Name: Dasatinib Dasatinib
Find On: PubMed — Wikipedia — Google
CAS Numbers: 302962-49-8 , 302962-49-8; 863127-77-9 , 863127-77-9 , [302962-49-8] , [863127-77-9]
863127-77-9; D06414; Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN)
BMS-354825, Sprycel, BMS354825, Dasatinib
BMS-354825; anh. dasatinib; anhydrous dasatinib; dasatinib (anh.)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.13 | 7.33 | -37.83 | 4 | 9 | 1 | 108 | 489.025 | 7 | ↓ |
Mid Mid (pH 6-8) | 3.13 | 7.4 | -39.94 | 4 | 9 | 1 | 108 | 489.025 | 7 | ↓ |
Mid Mid (pH 6-8) | 3.13 | 7.04 | -18.14 | 3 | 9 | 0 | 107 | 488.017 | 7 | ↓ |
Mid Mid (pH 6-8) | 3.13 | 9.7 | -105.45 | 5 | 9 | 2 | 109 | 490.033 | 7 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.28e-02 g/l | DrugBank-approved |
Purity | 95+% | Matrix Scientific |
UniProt Database Links | ACK1_HUMAN; CSF1R_HUMAN; CSF1R_MOUSE; LYN_HUMAN; LYN_MOUSE | ChEBI |
Therapy | antineoplastic | SMDC Pharmakon |
Patent Database Links | EP1977765; US2004073026; US2007179125; US2007249031; US2007259869; WO2007096393; WO2007096395; WO2007109178; WO2007113268; WO2007113269; WO2007113270; WO2007116025; WO2007120726; WO2007124498; WO2007128827; WO2007128829; WO2008115973; WO2008128009; WO2008 | ChEBI |
Warnings | IRRITANT | Matrix Scientific |
Target | Src, Bcr-Abl, c-Kit | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 590 | 0.26 | Binding ≤ 10μM |
ABL2-1-E | Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
ACK1-1-E | Tyrosine Kinase Non-receptor Protein 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.35 | Binding ≤ 10μM |
ACV1B-1-E | Activin Receptor Type-1B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 330 | 0.27 | Binding ≤ 10μM |
ACVL1-1-E | Serine/threonine-protein Kinase Receptor R3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 460 | 0.27 | Binding ≤ 10μM |
ACVR1-1-E | Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 620 | 0.26 | Binding ≤ 10μM |
ADCK3-1-E | Chaperone Activity Of Bc1 Complex-like, Mitochondrial (cluster #1 Of 1), Eukaryotic | Eukaryotes | 190 | 0.29 | Binding ≤ 10μM |
AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6485 | 0.22 | Binding ≤ 10μM |
AVR2A-1-E | Activin Receptor Type-2A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.28 | Binding ≤ 10μM |
AVR2B-1-E | Activin Receptor Type-2B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 570 | 0.26 | Binding ≤ 10μM |
BCR-1-E | Breakpoint Cluster Region Protein (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
BLK-1-E | Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
BMX-1-E | Tyrosine-protein Kinase BMX (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
BRAF-1-E | Serine/threonine-protein Kinase B-raf (cluster #1 Of 1), Eukaryotic | Eukaryotes | 570 | 0.26 | Binding ≤ 10μM |
BTK-1-E | Tyrosine-protein Kinase BTK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5 | 0.35 | Binding ≤ 10μM |
CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7 | 0.35 | Binding ≤ 10μM |
CSK-1-E | Tyrosine-protein Kinase CSK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
DDR1-1-E | Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
DDR2-1-E | Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3 | 0.36 | Binding ≤ 10μM |
DMPK-1-E | Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.25 | Binding ≤ 10μM |
E2AK4-1-E | Eukaryotic Translation Initiation Factor 2-alpha Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.25 | Binding ≤ 10μM |
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 79 | 0.30 | Binding ≤ 10μM |
EPHA1-1-E | Ephrin Type-A Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4 | 0.36 | Binding ≤ 10μM |
EPHA2-1-E | Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 137 | 0.29 | Binding ≤ 10μM |
EPHA3-1-E | Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
EPHA4-1-E | Ephrin Type-A Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
EPHA5-1-E | Ephrin Type-A Receptor 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
EPHA8-1-E | Ephrin Type-A Receptor 8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
EPHB1-1-E | Ephrin Type-B Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
EPHB2-1-E | Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4 | 0.36 | Binding ≤ 10μM |
EPHB3-1-E | Ephrin Type-B Receptor 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7 | 0.35 | Binding ≤ 10μM |
EPHB4-1-E | Ephrin Type-B Receptor 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
ERBB2-2-E | Receptor Protein-tyrosine Kinase ErbB-2 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 710 | 0.26 | Binding ≤ 10μM |
FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 880 | 0.26 | Binding ≤ 10μM |
FGFR2-1-E | Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.25 | Binding ≤ 10μM |
FGR-1-E | Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8100 | 0.22 | Binding ≤ 10μM |
FRK-1-E | Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
FYN-1-E | Tyrosine-protein Kinase FYN (cluster #1 Of 5), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3 | 0.36 | Binding ≤ 10μM |
HCK-1-E | Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
JAK2-1-E | Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1000 | 0.25 | Binding ≤ 10μM |
KC1A-1-E | Casein Kinase I Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
KC1E-1-E | Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1500 | 0.25 | Binding ≤ 10μM |
KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 93 | 0.30 | Binding ≤ 10μM |
KSYK-1-E | Tyrosine-protein Kinase SYK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2900 | 0.23 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 0 | 0.00 | Binding ≤ 10μM |
LIMK1-1-E | LIM Domain Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 570 | 0.26 | Binding ≤ 10μM |
LIMK2-1-E | LIM Domain Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 86 | 0.30 | Binding ≤ 10μM |
LYN-1-E | Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
M3K4-1-E | Mitogen-activated Protein Kinase Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 310 | 0.28 | Binding ≤ 10μM |
M4K1-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 980 | 0.25 | Binding ≤ 10μM |
M4K3-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 640 | 0.26 | Binding ≤ 10μM |
M4K4-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3100 | 0.23 | Binding ≤ 10μM |
M4K5-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 45 | 0.31 | Binding ≤ 10μM |
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 410 | 0.27 | Binding ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 100 | 0.30 | Binding ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.30 | Binding ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 495 | 0.27 | Binding ≤ 10μM |
MLTK-1-E | Mixed Lineage Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 45 | 0.31 | Binding ≤ 10μM |
MP2K1-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 1700 | 0.24 | Binding ≤ 10μM |
MP2K2-1-E | Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.24 | Binding ≤ 10μM |
MRCKA-1-E | Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2000 | 0.24 | Binding ≤ 10μM |
MRCKB-1-E | Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.24 | Binding ≤ 10μM |
MRCKG-1-E | Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.25 | Binding ≤ 10μM |
MST4-1-E | Serine/threonine-protein Kinase MST4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1900 | 0.24 | Binding ≤ 10μM |
NLK-1-E | Serine/threonine Protein Kinase NLK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 260 | 0.28 | Binding ≤ 10μM |
PGFRA-1-E | Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 63 | 0.31 | Binding ≤ 10μM |
PGFRB-1-E | Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 28 | 0.32 | Binding ≤ 10μM |
PMYT1-1-E | Tyrosine- And Threonine-specific Cdc2-inhibitory Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 130 | 0.29 | Binding ≤ 10μM |
PTK6-1-E | Tyrosine-protein Kinase BRK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9 | 0.34 | Binding ≤ 10μM |
RAF1-1-E | Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic | Eukaryotes | 570 | 0.26 | Binding ≤ 10μM |
RET-1-E | Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic | Eukaryotes | 730 | 0.26 | Binding ≤ 10μM |
RIPK2-1-E | Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 31 | 0.32 | Binding ≤ 10μM |
SIK1-1-E | Serine/threonine-protein Kinase SIK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4 | 0.36 | Binding ≤ 10μM |
SIK2-1-E | Serine/threonine-protein Kinase SIK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.35 | Binding ≤ 10μM |
SLK-1-E | Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 720 | 0.26 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 14 | 0.33 | Binding ≤ 10μM |
SRMS-1-E | Tyrosine-protein Kinase Srms (cluster #1 Of 1), Eukaryotic | Eukaryotes | 13 | 0.33 | Binding ≤ 10μM |
STK10-1-E | Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1200 | 0.25 | Binding ≤ 10μM |
STK36-1-E | Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.28 | Binding ≤ 10μM |
TBA1A-1-E | Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic | Eukaryotes | 55 | 0.31 | Binding ≤ 10μM |
TEC-1-E | Tyrosine-protein Kinase TEC (cluster #1 Of 1), Eukaryotic | Eukaryotes | 297 | 0.28 | Binding ≤ 10μM |
TESK1-1-E | Dual Specificity Testis-specific Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 33 | 0.32 | Binding ≤ 10μM |
TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 230 | 0.28 | Binding ≤ 10μM |
TGFR2-1-E | TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2900 | 0.23 | Binding ≤ 10μM |
TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 11 | 0.34 | Binding ≤ 10μM |
TNIK-1-E | TRAF2- And NCK-interacting Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2000 | 0.24 | Binding ≤ 10μM |
TXK-1-E | Tyrosine-protein Kinase TXK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.37 | Binding ≤ 10μM |
VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.22 | Binding ≤ 10μM |
VGFR2-2-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2360 | 0.24 | Binding ≤ 10μM |
WEE1-1-E | Serine/threonine-protein Kinase WEE1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7000 | 0.22 | Binding ≤ 10μM |
YES-1-E | Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.38 | Binding ≤ 10μM |
Z80186-1-O | K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other | Other | 1 | 0.38 | Functional ≤ 10μM |
Z80390-1-O | PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other | Other | 9 | 0.34 | Functional ≤ 10μM |
Z81017-1-O | WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other | Other | 52 | 0.31 | Functional ≤ 10μM |
Z81252-3-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other | Other | 12 | 0.34 | Functional ≤ 10μM |
Z81338-1-O | T-cells (cluster #1 Of 3), Other | Other | 3 | 0.36 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 620 | 0.26 | Binding ≤ 1μM |
ACV1B_HUMAN | P36896 | Activin Receptor Type-1B, Human | 330 | 0.27 | Binding ≤ 1μM |
AVR2A_HUMAN | P27037 | Activin Receptor Type-2A, Human | 210 | 0.28 | Binding ≤ 1μM |
AVR2B_HUMAN | Q13705 | Activin Receptor Type-2B, Human | 570 | 0.26 | Binding ≤ 1μM |
BCR_HUMAN | P11274 | Breakpoint Cluster Region Protein, Human | 0.8 | 0.39 | Binding ≤ 1μM |
KC1A_HUMAN | P48729 | Casein Kinase I Alpha, Human | 1 | 0.38 | Binding ≤ 1μM |
ADCK3_HUMAN | Q8NI60 | Chaperone Activity Of Bc1 Complex-like, Mitochondrial, Human | 190 | 0.29 | Binding ≤ 1μM |
DDR2_HUMAN | Q16832 | Discoidin Domain-containing Receptor 2, Human | 3.2 | 0.36 | Binding ≤ 1μM |
MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 1000 | 0.25 | Binding ≤ 1μM |
TESK1_HUMAN | Q15569 | Dual Specificity Testis-specific Protein Kinase 1, Human | 33 | 0.32 | Binding ≤ 1μM |
EPHA1_HUMAN | P21709 | Ephrin Type-A Receptor 1, Human | 4.1 | 0.36 | Binding ≤ 1μM |
EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 0.85 | 0.38 | Binding ≤ 1μM |
EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 0.1 | 0.42 | Binding ≤ 1μM |
EPHA4_HUMAN | P54764 | Ephrin Type-A Receptor 4, Human | 1.2 | 0.38 | Binding ≤ 1μM |
EPHA5_HUMAN | P54756 | Ephrin Type-A Receptor 5, Human | 0.24 | 0.41 | Binding ≤ 1μM |
EPHA8_HUMAN | P29322 | Ephrin Type-A Receptor 8, Human | 0.24 | 0.41 | Binding ≤ 1μM |
EPHB1_HUMAN | P54762 | Ephrin Type-B Receptor 1, Human | 0.45 | 0.40 | Binding ≤ 1μM |
EPHB2_HUMAN | P29323 | Ephrin Type-B Receptor 2, Human | 0.39 | 0.40 | Binding ≤ 1μM |
EPHB3_HUMAN | P54753 | Ephrin Type-B Receptor 3, Human | 6.9 | 0.35 | Binding ≤ 1μM |
EPHB4_HUMAN | P54760 | Ephrin Type-B Receptor 4, Human | 0.34 | 0.40 | Binding ≤ 1μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 110 | 0.30 | Binding ≤ 1μM |
DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 0.69 | 0.39 | Binding ≤ 1μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 880 | 0.26 | Binding ≤ 1μM |
LIMK1_HUMAN | P53667 | LIM Domain Kinase 1, Human | 114 | 0.29 | Binding ≤ 1μM |
LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 86 | 0.30 | Binding ≤ 1μM |
CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 0.58 | 0.39 | Binding ≤ 1μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 100 | 0.30 | Binding ≤ 1μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 100 | 0.30 | Binding ≤ 1μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 100 | 0.30 | Binding ≤ 1μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 100 | 0.30 | Binding ≤ 1μM |
M3K4_HUMAN | Q9Y6R4 | Mitogen-activated Protein Kinase Kinase Kinase 4, Human | 310 | 0.28 | Binding ≤ 1μM |
M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 980 | 0.25 | Binding ≤ 1μM |
M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 640 | 0.26 | Binding ≤ 1μM |
M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 45 | 0.31 | Binding ≤ 1μM |
MLTK_HUMAN | Q9NYL2 | Mixed Lineage Kinase 7, Human | 45 | 0.31 | Binding ≤ 1μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 0.47 | 0.40 | Binding ≤ 1μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 0.63 | 0.39 | Binding ≤ 1μM |
ERBB2_HUMAN | P04626 | Receptor Protein-tyrosine Kinase ErbB-2, Human | 710 | 0.26 | Binding ≤ 1μM |
NLK_HUMAN | Q9UBE8 | Serine/threonine Protein Kinase NLK, Human | 260 | 0.28 | Binding ≤ 1μM |
SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 720 | 0.26 | Binding ≤ 1μM |
STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 210 | 0.28 | Binding ≤ 1μM |
BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 500 | 0.27 | Binding ≤ 1μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 2.6 | 0.36 | Binding ≤ 1μM |
RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 164 | 0.29 | Binding ≤ 1μM |
ACVL1_HUMAN | P37023 | Serine/threonine-protein Kinase Receptor R3, Human | 460 | 0.27 | Binding ≤ 1μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 109 | 0.30 | Binding ≤ 1μM |
SIK1_HUMAN | P57059 | Serine/threonine-protein Kinase SIK1, Human | 3.9 | 0.36 | Binding ≤ 1μM |
SIK2_HUMAN | Q9H0K1 | Serine/threonine-protein Kinase SIK2, Human | 6.4 | 0.35 | Binding ≤ 1μM |
TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 11 | 0.34 | Binding ≤ 1μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 0.62 | 0.39 | Binding ≤ 1μM |
TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 230 | 0.28 | Binding ≤ 1μM |
TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 55 | 0.31 | Binding ≤ 1μM |
ACK1_HUMAN | Q07912 | Tyrosine Kinase Non-receptor Protein 2, Human | 5.6 | 0.35 | Binding ≤ 1μM |
PMYT1_HUMAN | Q99640 | Tyrosine- And Threonine-specific Cdc2-inhibitory Kinase, Human | 130 | 0.29 | Binding ≤ 1μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 0.53 | 0.39 | Binding ≤ 1μM |
ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 0.17 | 0.41 | Binding ≤ 1μM |
BLK_HUMAN | P51451 | Tyrosine-protein Kinase BLK, Human | 0.21 | 0.41 | Binding ≤ 1μM |
BLK_MOUSE | P16277 | Tyrosine-protein Kinase BLK, Mouse | 8 | 0.34 | Binding ≤ 1μM |
BMX_HUMAN | P51813 | Tyrosine-protein Kinase BMX, Human | 1.4 | 0.38 | Binding ≤ 1μM |
PTK6_HUMAN | Q13882 | Tyrosine-protein Kinase BRK, Human | 7.8 | 0.34 | Binding ≤ 1μM |
BTK_HUMAN | Q06187 | Tyrosine-protein Kinase BTK, Human | 1.3 | 0.38 | Binding ≤ 1μM |
CSK_HUMAN | P41240 | Tyrosine-protein Kinase CSK, Human | 1 | 0.38 | Binding ≤ 1μM |
FGR_HUMAN | P09769 | Tyrosine-protein Kinase FGR, Human | 0.5 | 0.39 | Binding ≤ 1μM |
FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 0.31 | 0.40 | Binding ≤ 1μM |
FYN_HUMAN | P06241 | Tyrosine-protein Kinase FYN, Human | 0.2 | 0.41 | Binding ≤ 1μM |
HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 0.35 | 0.40 | Binding ≤ 1μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1000 | 0.25 | Binding ≤ 1μM |
LCK_MOUSE | P06240 | Tyrosine-protein Kinase LCK, Mouse | 0.1 | 0.42 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 0.2 | 0.41 | Binding ≤ 1μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 0.57 | 0.39 | Binding ≤ 1μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 390 | 0.27 | Binding ≤ 1μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 0.21 | 0.41 | Binding ≤ 1μM |
SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 0.4 | 0.40 | Binding ≤ 1μM |
SRMS_HUMAN | Q9H3Y6 | Tyrosine-protein Kinase Srms, Human | 13 | 0.33 | Binding ≤ 1μM |
TEC_HUMAN | P42680 | Tyrosine-protein Kinase TEC, Human | 13 | 0.33 | Binding ≤ 1μM |
TXK_HUMAN | P42681 | Tyrosine-protein Kinase TXK, Human | 0.3 | 0.40 | Binding ≤ 1μM |
YES_HUMAN | P07947 | Tyrosine-protein Kinase YES, Human | 0.3 | 0.40 | Binding ≤ 1μM |
ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 620 | 0.26 | Binding ≤ 10μM |
ACV1B_HUMAN | P36896 | Activin Receptor Type-1B, Human | 330 | 0.27 | Binding ≤ 10μM |
AVR2A_HUMAN | P27037 | Activin Receptor Type-2A, Human | 210 | 0.28 | Binding ≤ 10μM |
AVR2B_HUMAN | Q13705 | Activin Receptor Type-2B, Human | 570 | 0.26 | Binding ≤ 10μM |
BCR_HUMAN | P11274 | Breakpoint Cluster Region Protein, Human | 0.8 | 0.39 | Binding ≤ 10μM |
KC1A_HUMAN | P48729 | Casein Kinase I Alpha, Human | 1 | 0.38 | Binding ≤ 10μM |
KC1E_HUMAN | P49674 | Casein Kinase I Epsilon, Human | 1500 | 0.25 | Binding ≤ 10μM |
ADCK3_HUMAN | Q8NI60 | Chaperone Activity Of Bc1 Complex-like, Mitochondrial, Human | 190 | 0.29 | Binding ≤ 10μM |
DDR2_HUMAN | Q16832 | Discoidin Domain-containing Receptor 2, Human | 3.2 | 0.36 | Binding ≤ 10μM |
MP2K1_HUMAN | Q02750 | Dual Specificity Mitogen-activated Protein Kinase Kinase 1, Human | 1000 | 0.25 | Binding ≤ 10μM |
MP2K2_HUMAN | P36507 | Dual Specificity Mitogen-activated Protein Kinase Kinase 2, Human | 1400 | 0.25 | Binding ≤ 10μM |
TESK1_HUMAN | Q15569 | Dual Specificity Testis-specific Protein Kinase 1, Human | 33 | 0.32 | Binding ≤ 10μM |
EPHA1_HUMAN | P21709 | Ephrin Type-A Receptor 1, Human | 4.1 | 0.36 | Binding ≤ 10μM |
EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 0.85 | 0.38 | Binding ≤ 10μM |
EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 0.1 | 0.42 | Binding ≤ 10μM |
EPHA4_HUMAN | P54764 | Ephrin Type-A Receptor 4, Human | 1.2 | 0.38 | Binding ≤ 10μM |
EPHA5_HUMAN | P54756 | Ephrin Type-A Receptor 5, Human | 0.24 | 0.41 | Binding ≤ 10μM |
EPHA8_HUMAN | P29322 | Ephrin Type-A Receptor 8, Human | 0.24 | 0.41 | Binding ≤ 10μM |
EPHB1_HUMAN | P54762 | Ephrin Type-B Receptor 1, Human | 0.45 | 0.40 | Binding ≤ 10μM |
EPHB2_HUMAN | P29323 | Ephrin Type-B Receptor 2, Human | 0.39 | 0.40 | Binding ≤ 10μM |
EPHB3_HUMAN | P54753 | Ephrin Type-B Receptor 3, Human | 6.9 | 0.35 | Binding ≤ 10μM |
EPHB4_HUMAN | P54760 | Ephrin Type-B Receptor 4, Human | 0.34 | 0.40 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 110 | 0.30 | Binding ≤ 10μM |
DDR1_HUMAN | Q08345 | Epithelial Discoidin Domain-containing Receptor 1, Human | 0.69 | 0.39 | Binding ≤ 10μM |
E2AK4_HUMAN | Q9P2K8 | Eukaryotic Translation Initiation Factor 2-alpha Kinase 4, Human | 1600 | 0.25 | Binding ≤ 10μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 3700 | 0.23 | Binding ≤ 10μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 1400 | 0.25 | Binding ≤ 10μM |
LIMK1_HUMAN | P53667 | LIM Domain Kinase 1, Human | 114 | 0.29 | Binding ≤ 10μM |
LIMK2_HUMAN | P53671 | LIM Domain Kinase 2, Human | 86 | 0.30 | Binding ≤ 10μM |
CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 0.58 | 0.39 | Binding ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 100 | 0.30 | Binding ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 100 | 0.30 | Binding ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 100 | 0.30 | Binding ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 100 | 0.30 | Binding ≤ 10μM |
M3K4_HUMAN | Q9Y6R4 | Mitogen-activated Protein Kinase Kinase Kinase 4, Human | 310 | 0.28 | Binding ≤ 10μM |
M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 980 | 0.25 | Binding ≤ 10μM |
M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 640 | 0.26 | Binding ≤ 10μM |
M4K4_HUMAN | O95819 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 4, Human | 3100 | 0.23 | Binding ≤ 10μM |
M4K5_HUMAN | Q9Y4K4 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 5, Human | 45 | 0.31 | Binding ≤ 10μM |
MLTK_HUMAN | Q9NYL2 | Mixed Lineage Kinase 7, Human | 45 | 0.31 | Binding ≤ 10μM |
DMPK_HUMAN | Q09013 | Myotonin-protein Kinase, Human | 1300 | 0.25 | Binding ≤ 10μM |
PGFRA_HUMAN | P16234 | Platelet-derived Growth Factor Receptor Alpha, Human | 0.47 | 0.40 | Binding ≤ 10μM |
PGFRB_HUMAN | P09619 | Platelet-derived Growth Factor Receptor Beta, Human | 0.63 | 0.39 | Binding ≤ 10μM |
ERBB2_HUMAN | P04626 | Receptor Protein-tyrosine Kinase ErbB-2, Human | 1400 | 0.25 | Binding ≤ 10μM |
NLK_HUMAN | Q9UBE8 | Serine/threonine Protein Kinase NLK, Human | 260 | 0.28 | Binding ≤ 10μM |
STK10_HUMAN | O94804 | Serine/threonine-protein Kinase 10, Human | 1200 | 0.25 | Binding ≤ 10μM |
SLK_HUMAN | Q9H2G2 | Serine/threonine-protein Kinase 2, Human | 720 | 0.26 | Binding ≤ 10μM |
STK36_HUMAN | Q9NRP7 | Serine/threonine-protein Kinase 36, Human | 210 | 0.28 | Binding ≤ 10μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 6485 | 0.22 | Binding ≤ 10μM |
BRAF_HUMAN | P15056 | Serine/threonine-protein Kinase B-raf, Human | 500 | 0.27 | Binding ≤ 10μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 2.6 | 0.36 | Binding ≤ 10μM |
MRCKB_HUMAN | Q9Y5S2 | Serine/threonine-protein Kinase MRCK Beta, Human | 2100 | 0.24 | Binding ≤ 10μM |
MRCKG_HUMAN | Q6DT37 | Serine/threonine-protein Kinase MRCK Gamma, Human | 1200 | 0.25 | Binding ≤ 10μM |
MRCKA_HUMAN | Q5VT25 | Serine/threonine-protein Kinase MRCK-A, Human | 2000 | 0.24 | Binding ≤ 10μM |
MST4_HUMAN | Q9P289 | Serine/threonine-protein Kinase MST4, Human | 1900 | 0.24 | Binding ≤ 10μM |
RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 164 | 0.29 | Binding ≤ 10μM |
ACVL1_HUMAN | P37023 | Serine/threonine-protein Kinase Receptor R3, Human | 460 | 0.27 | Binding ≤ 10μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 109 | 0.30 | Binding ≤ 10μM |
SIK1_HUMAN | P57059 | Serine/threonine-protein Kinase SIK1, Human | 3.9 | 0.36 | Binding ≤ 10μM |
SIK2_HUMAN | Q9H0K1 | Serine/threonine-protein Kinase SIK2, Human | 6.4 | 0.35 | Binding ≤ 10μM |
TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 11 | 0.34 | Binding ≤ 10μM |
WEE1_HUMAN | P30291 | Serine/threonine-protein Kinase WEE1, Human | 7000 | 0.22 | Binding ≤ 10μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 0.62 | 0.39 | Binding ≤ 10μM |
TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 230 | 0.28 | Binding ≤ 10μM |
TGFR2_HUMAN | P37173 | TGF-beta Receptor Type II, Human | 2900 | 0.23 | Binding ≤ 10μM |
TNIK_HUMAN | Q9UKE5 | TRAF2- And NCK-interacting Kinase, Human | 2000 | 0.24 | Binding ≤ 10μM |
TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 55 | 0.31 | Binding ≤ 10μM |
ACK1_HUMAN | Q07912 | Tyrosine Kinase Non-receptor Protein 2, Human | 5.6 | 0.35 | Binding ≤ 10μM |
PMYT1_HUMAN | Q99640 | Tyrosine- And Threonine-specific Cdc2-inhibitory Kinase, Human | 130 | 0.29 | Binding ≤ 10μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 0.53 | 0.39 | Binding ≤ 10μM |
ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 0.17 | 0.41 | Binding ≤ 10μM |
BLK_HUMAN | P51451 | Tyrosine-protein Kinase BLK, Human | 0.21 | 0.41 | Binding ≤ 10μM |
BLK_MOUSE | P16277 | Tyrosine-protein Kinase BLK, Mouse | 8 | 0.34 | Binding ≤ 10μM |
BMX_HUMAN | P51813 | Tyrosine-protein Kinase BMX, Human | 1.4 | 0.38 | Binding ≤ 10μM |
PTK6_HUMAN | Q13882 | Tyrosine-protein Kinase BRK, Human | 7.8 | 0.34 | Binding ≤ 10μM |
BTK_HUMAN | Q06187 | Tyrosine-protein Kinase BTK, Human | 1.3 | 0.38 | Binding ≤ 10μM |
CSK_HUMAN | P41240 | Tyrosine-protein Kinase CSK, Human | 1 | 0.38 | Binding ≤ 10μM |
FGR_HUMAN | P09769 | Tyrosine-protein Kinase FGR, Human | 0.5 | 0.39 | Binding ≤ 10μM |
FRK_HUMAN | P42685 | Tyrosine-protein Kinase FRK, Human | 0.31 | 0.40 | Binding ≤ 10μM |
FYN_HUMAN | P06241 | Tyrosine-protein Kinase FYN, Human | 0.2 | 0.41 | Binding ≤ 10μM |
HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 0.35 | 0.40 | Binding ≤ 10μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1000 | 0.25 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 0.2 | 0.41 | Binding ≤ 10μM |
LCK_MOUSE | P06240 | Tyrosine-protein Kinase LCK, Mouse | 0.1 | 0.42 | Binding ≤ 10μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 0.57 | 0.39 | Binding ≤ 10μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 8100 | 0.22 | Binding ≤ 10μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 2100 | 0.24 | Binding ≤ 10μM |
SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 0.4 | 0.40 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 0.21 | 0.41 | Binding ≤ 10μM |
SRMS_HUMAN | Q9H3Y6 | Tyrosine-protein Kinase Srms, Human | 13 | 0.33 | Binding ≤ 10μM |
KSYK_HUMAN | P43405 | Tyrosine-protein Kinase SYK, Human | 2900 | 0.23 | Binding ≤ 10μM |
TEC_HUMAN | P42680 | Tyrosine-protein Kinase TEC, Human | 13 | 0.33 | Binding ≤ 10μM |
TXK_HUMAN | P42681 | Tyrosine-protein Kinase TXK, Human | 0.3 | 0.40 | Binding ≤ 10μM |
YES_HUMAN | P07947 | Tyrosine-protein Kinase YES, Human | 0.3 | 0.40 | Binding ≤ 10μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 5000 | 0.22 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 2360 | 0.24 | Binding ≤ 10μM |
Z80186 | Z80186 | K562 (Erythroleukemia Cells) | 1 | 0.38 | Functional ≤ 10μM |
Z81252 | Z81252 | MDA-MB-231 (Breast Adenocarcinoma Cells) | 12 | 0.34 | Functional ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 9.4 | 0.34 | Functional ≤ 10μM |
Z81338 | Z81338 | T-cells | 3 | 0.36 | Functional ≤ 10μM |
Z81017 | Z81017 | WiDr (Colon Adenocarcinoma Cells) | 52 | 0.31 | Functional ≤ 10μM |
Description | Species |
---|---|
Activated point mutants of FGFR2 | |
activated TAK1 mediates p38 MAPK activation | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
APC truncation mutants have impaired AXIN binding | |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
Apoptotic cleavage of cellular proteins | |
ARMS-mediated activation | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
c-src mediated regulation of Cx43 function and closure of gap junctions | |
Ca2+ pathway | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDO in myogenesis | |
Cell surface interactions at the vascular wall | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Circadian Clock | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation through the activation of Ras | |
CRMPs in Sema3A signaling | |
CTLA4 inhibitory signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin E associated events during G1/S transition | |
DAP12 signaling | |
DCC mediated attractive signaling | |
Degradation of beta-catenin by the destruction complex | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
Downregulation of ERBB2:ERBB3 signaling | |
Downregulation of TGF-beta receptor signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
DSCAM interactions | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
ERK/MAPK targets | |
ERK1 activation | |
ERK2 activation | |
Factors involved in megakaryocyte development and platelet production | |
Fc epsilon receptor (FCERI) signaling | |
FCERI mediated Ca+2 mobilization | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
FCGR activation | |
Formation of tubulin folding intermediates by CCT/TriC | |
Frs2-mediated activation | |
G2/M DNA replication checkpoint | |
GAB1 signalosome | |
Gap junction assembly | |
Generation of second messenger molecules | |
Golgi Associated Vesicle Biogenesis | |
GP1b-IX-V activation signalling | |
GPVI-mediated activation cascade | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
GRB2:SOS provides linkage to MAPK signaling for Integrins | |
GRB7 events in ERBB2 signaling | |
Growth hormone receptor signaling | |
Integrin alphaIIb beta3 signaling | |
Integrin cell surface interactions | |
Interferon gamma signaling | |
Interleukin receptor SHC signaling | |
Interleukin-1 signaling | |
Interleukin-2 signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
Interleukin-6 signaling | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
Kinesins | |
KSRP destabilizes mRNA | |
L1CAM interactions | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MEK activation | |
MHC class II antigen presentation | |
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Mitotic Prometaphase | |
MyD88:Mal cascade initiated on plasma membrane | |
NCAM signaling for neurite out-growth | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
Nephrin interactions | |
Netrin mediated repulsion signals | |
Neurophilin interactions with VEGF and VEGFR | |
NOD1/2 Signaling Pathway | |
Non-integrin membrane-ECM interactions | |
Oxidative Stress Induced Senescence | |
p130Cas linkage to MAPK signaling for integrins | |
p38MAPK events | |
p75NTR recruits signalling complexes | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
Platelet Adhesion to exposed collagen | |
Platelet sensitization by LDL | |
PLCG1 events in ERBB2 signaling | |
Polo-like kinase mediated events | |
Post-chaperonin tubulin folding pathway | |
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | |
Prefoldin mediated transfer of substrate to CCT/TriC | |
Prolactin receptor signaling | |
RAF activation | |
RAF phosphorylates MEK | |
Rap1 signalling | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Recycling pathway of L1 | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of cytoskeletal remodeling and cell spreading by IPP complex componen | |
Regulation of IFNG signaling | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of signaling by CBL | |
Regulation of signaling by NODAL | |
Resolution of Sister Chromatid Cohesion | |
Rho GTPase cycle | |
RMTs methylate histone arginines | |
Role of Abl in Robo-Slit signaling | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Role of phospholipids in phagocytosis | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
Sema3A PAK dependent Axon repulsion | |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | |
Sema4D induced cell migration and growth-cone collapse | |
Separation of Sister Chromatids | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal regulatory protein (SIRP) family interactions | |
Signal transduction by L1 | |
Signaling by activated point mutants of FGFR1 | |
Signaling by Activin | |
Signaling by BMP | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by FGFR | |
Signaling by FGFR mutants | |
Signaling by FGFR1 fusion mutants | |
Signaling by FGFR2 amplification mutants | |
Signaling by Leptin | |
Signaling by NODAL | |
Signaling by PDGF | |
Signaling by SCF-KIT | |
Signalling to p38 via RIT and RIN | |
SMAD2/3 MH2 Domain Mutants in Cancer | |
SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
Spry regulation of FGF signaling | |
Stimuli-sensing channels | |
T41 mutants of beta-catenin aren't phosphorylated | |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
TGF-beta receptor signaling activates SMADs | |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
TGFBR1 KD Mutants in Cancer | |
TGFBR1 LBD Mutants in Cancer | |
TGFBR2 Kinase Domain Mutants in Cancer | |
TGFBR2 MSI Frameshift Mutants in Cancer | |
Thrombin signalling through proteinase activated receptors (PARs) | |
Translocation of GLUT4 to the plasma membrane | |
Translocation of ZAP-70 to Immunological synapse | |
truncations of AMER1 destabilize the destruction complex | |
Uptake and function of anthrax toxins | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation | |
WNT mediated activation of DVL |